IRBESARTAN HCT Zentiva cpr pell 300/25mg 98 pce

7680622780066 CH-62278 C09DA04 02.07.2.
IRBESARTAN HCT Zentiva cpr pell 300/25mg 98 pce
IRBESARTAN HCT Zentiva cpr pell 300/25mg 98 pce
1 / 2
google

Details

Product number
6227803
CPT
-
Packaging group
98
Unit
Tablette(n)
Composition
irbesartanum 300 mg, hydrochlorothiazidum 25 mg, lactosum monohydricum 53.3 mg, cellulosum microcristallinum, carmellosum natricum conexum, amylum pregelificatum, E 172 (rubrum), E 172 (flavum), magnesii stearas, silica colloidalis anhydrica, Überzug: lactosum monohydricum 7.56 mg, hypromellosum, E 171, macrogolum 3350, E 172 (rubrum), E 172 (nigrum), cera carnauba, pro compresso obducto corresp. natrium 2.7345 mg.

Articles (1)

Irbesartan HCT Zentiva 300/25 mg, Filmtabletten
Filmtabletten
98
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/08/2025
Patient information leaflet
Français
26/08/2025
Patient information leaflet
Italien
26/08/2025
Professional SmPC
Allemand
26/08/2025
Professional SmPC
Français
26/08/2025
Professional SmPC
Italien
26/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
53.3 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.56 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
2.7345 MG Substance HBESI

Reimbursement information

Public price
CHF 64.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2014

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
62278
Drug name
Irbesartan HCT Zentiva, Filmtabletten
Galenic form
FILM
ATC Code
C09DA04
Authorization status
Z
Dispensation category
B
First authorization
27/07/2011
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
IRBESARTAN HCT Zentiva cpr pell 300/25mg 98 pce
Description (DE)
IRBESARTAN HCT Zentiva Filmtabl 300/25mg 98 Stk
Market launch
27/07/2011
Narcotic (BTM)
No

Original drug

CoAprovel, comprimés filmés
CHF 27.45
View original

Other packaging sizes

IRBESARTAN HCT Zentiva cpr pell 150/12.5mg 28 pce
28 TABL
View
IRBESARTAN HCT Zentiva cpr pell 150/12.5mg 98 pce
98 TABL
View
IRBESARTAN HCT Zentiva cpr pell 300/12.5mg 28 pce
28 TABL
View
IRBESARTAN HCT Zentiva cpr pell 300/12.5mg 98 pce
98 TABL
View
IRBESARTAN HCT Zentiva cpr pell 300/25mg 28 pce
28 TABL
View